Clinical Trial Update: Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide in newly diagnosed anaplastic oligodendroglioma or mixed oligoastrocytoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Oligodendroglioma
• Brain Tumor
• Central Nervous System Tumor
• Mixed Oligodendroastrocytoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Central Nervous System Tumors, Brain Tumor | Phase 2 | Status: COMPLETED